Joseph A. Sparano
- Oncology top 0.05%
- Cancer Treatment and Pharmacology 96
- HER2/EGFR in Cancer Research 83
- Viral-associated cancers and disorders 50
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 102
- Cancer Genomics and Diagnostics 32
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 59
- Immunology top 1%
- Pulmonary and Respiratory Medicine top 0.5%
- Advanced Breast Cancer Therapies 54
-
- Chronic Lymphocytic Leukemia Research 30
- Co-authors
- Nancy E. DavidsonGeorge W. SledgeAntonio C. WolffEdith A. PerezSilvana MartinoWilliam C. WoodRobert J. GraySoonmyung Paik
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Joseph A. Sparano
377 papers receiving 15.5k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 10.4k
- Cancer Research 5.3k
- Pathology and Forensic Medicine 2.3k
- Immunology 1.7k
- Pulmonary and Respiratory Medicine 2.7k
Countries citing papers authored by Joseph A. Sparano
This map shows the geographic impact of Joseph A. Sparano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Sparano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Sparano more than expected).
Fields of papers citing papers by Joseph A. Sparano
This network shows the impact of papers produced by Joseph A. Sparano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Sparano. The network helps show where Joseph A. Sparano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joseph A. Sparano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 4 | |
| 5 | Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital Systembreakdown → | 2020 | 521 |
| 6 | 2018 | 9 | |
| 7 | Gene Expression Assays in Early-Stage Breast Cancer. | 2018 | 1 |
| 8 | 2017 | 6 | |
| 9 | 2017 | 362 | |
| 10 | 2016 | 66 | |
| 11 | 2015 | 54 | |
| 12 | 2014 | 131 | |
| 13 | Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199breakdown → | 2014 | 953 |
| 14 | 2013 | 47 | |
| 15 | 2013 | 19 | |
| 16 | 2013 | 15 | |
| 17 | 2012 | 48 | |
| 18 | 2009 | 21 | |
| 19 | 2006 | 54 | |
| 20 | 2003 | 28 |
About Joseph A. Sparano
Joseph A. Sparano is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 397 papers that have together received 15.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (102 papers), Cancer Treatment and Pharmacology (96 papers), HER2/EGFR in Cancer Research (83 papers), Lymphoma Diagnosis and Treatment (59 papers), Advanced Breast Cancer Therapies (54 papers), Viral-associated cancers and disorders (50 papers), Cancer Genomics and Diagnostics (32 papers) and Chronic Lymphocytic Leukemia Research (30 papers). The work is most often cited by research in Oncology (10.4k citations), Cancer Research (5.3k citations) and Pathology and Forensic Medicine (2.3k citations). Joseph A. Sparano has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Nancy E. Davidson, George W. Sledge, Antonio C. Wolff, Edith A. Perez, Silvana Martino, William C. Wood, Robert J. Gray, Soonmyung Paik, Lori J. Goldstein and Molin Wang. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.